Official Title: “A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.”

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Study Type: Observational

Study Design: Natural History, Longitudinal, Convenience Sample, Prospective Study

Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.

Inclusion Criteria:

• Age 13-45 presents at the ambulatory surgery at Grady Memorial Hospital Want to use either oral contraceptive pills, ortho evra or depo provera?

Exclusion Criteria:

• Leaving the Atlanta area within 6 months? Desires pregnancy within the next 6 months?
• Unable to provide contact information? contraindications to hormonal contraceptive.

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 45 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Lead Sponsor: Emory University

Overall Clinical Trial Officials and Contacts

Carrie Cwiak, MD, MPH Principal Investigator Emory University  

Information obtained from ClinicalTrials.gov on August 29, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00253019

Study ID Number: 518-2003

ClinicalTrials.gov Identifier: NCT00253019

Health Authority: United States: Institutional Review Board